Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-036073

Director sold 7,100 shares at $18.03 ($127,987)

  • Director acquired 8,289 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Schoeneck James A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-07 Grant or award : show line 1 in the form 10b5-1 +8,289 28,766 D
2023-06-07 Sale : show line 2 in the form 10b5-1 −7,100 $18.03 $127,987 73,722 I
Open-market sales · 7,100 sh · avg $18.03 · $127,987

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-07 Grant or award : show line 3 in the form 10b5-1 Stock Option (Right to Buy) +12,666 12,666 D
Loading xslF345X04/doc4.xml…